Literature DB >> 19907944

Acanthameba meningitis with successful outcome.

Ajit Saxena1, Sumit Mittal, Purbi Burman, Pankaj Garg.   

Abstract

We report a rare cause of sub acute meningitis in a 15-yr-old immunocompetent female child with successful outcome. The etiological agent was Acanthamoeba. The child was successfully treat with combination of Ketoconazole. Rifampicin, cotrimoxa zole and for a period of 9 month.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19907944     DOI: 10.1007/s12098-009-0205-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  12 in total

1.  Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials.

Authors:  T Singhal; A Bajpai; V Kalra; S K Kabra; J C Samantaray; G Satpathy; A K Gupta
Journal:  Pediatr Infect Dis J       Date:  2001-06       Impact factor: 2.129

2.  Acanthameba meningoencephalitis: a case report.

Authors:  A Hamide; E Sarkar; N Kumar; A K Das; S K Narayan; S C Parija
Journal:  Neurol India       Date:  2002-12       Impact factor: 2.117

3.  Primary amebic meningoencephalitis.

Authors:  S L Tungikar; A G Kulkarni; A D Deshpande; V S Gosavi
Journal:  J Assoc Physicians India       Date:  2006-04

4.  Successful treatment of acanthamoeba meningoencephalitis during induction therapy of childhood acute lymphoblastic leukemia.

Authors:  Deepak Gupta; Gita Satpathy Panda; Sameer Bakhshi
Journal:  Pediatr Blood Cancer       Date:  2008-06       Impact factor: 3.167

5.  Acanthamoeba meningoencephalitis complicating pyogenic meningitis.

Authors:  S C Karande; K R Lahiri; S S Sheth; U S Nadkarni; M K Jain; M D Shah
Journal:  Indian Pediatr       Date:  1991-07       Impact factor: 1.411

6.  Primary amoebic meningo-encephalitis in two Indian children.

Authors:  N R Pan; B C Roy; T N Ghosh
Journal:  J Indian Med Assoc       Date:  1971-03-01

7.  Granulomatous brain tumor caused by Acanthamoeba. Case report.

Authors:  S K Ofori-Kwakye; D G Sidebottom; J Herbert; E G Fischer; G S Visvesvara
Journal:  J Neurosurg       Date:  1986-03       Impact factor: 5.115

8.  Amebic meningoencephalitis: spectrum of imaging findings.

Authors:  P Singh; R Kochhar; R K Vashishta; N Khandelwal; S Prabhakar; S Mohindra; P Singhi
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

9.  Primary amebic meningoencephalitis caused by Acanthamoeba: successfully treated with cotrimoxazole.

Authors:  P P Sharma; P Gupta; M V Murali; V G Ramachandran
Journal:  Indian Pediatr       Date:  1993-10       Impact factor: 1.411

10.  Isolation of Acanthamoeba culbertsoni from a patient with meningitis.

Authors:  M K Lalitha; V Anandi; A Srivastava; K Thomas; A M Cherian; S M Chandi
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

View more
  6 in total

1.  Acanthamoeba meningoencephalitis in immunocompetent: A case report and review of literature.

Authors:  Vinay Khanna; Ba Shastri; G Anusha; Chiranjay Mukhopadhayay; Ruchee Khanna
Journal:  Trop Parasitol       Date:  2014-07

Review 2.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 3.  Antiparasitic therapy.

Authors:  Shanthi Kappagoda; Upinder Singh; Brian G Blackburn
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

4.  Central nervous system infection with Acanthamoeba in a malnourished child.

Authors:  Sumeeta Khurana; Abhishek Mewara; Sanjay Verma; Siddharth K Totadri
Journal:  BMJ Case Rep       Date:  2012-10-24

5.  Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.

Authors:  Duncan Webster; Imran Umar; Imram Umar; George Kolyvas; Juan Bilbao; Marie-Christine Guiot; Kevin Duplisea; Yvonne Qvarnstrom; Govinda S Visvesvara
Journal:  Am J Trop Med Hyg       Date:  2012-08-06       Impact factor: 2.345

Review 6.  Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.

Authors:  Alexandre Taravaud; Zineb Fechtali-Moute; Philippe M Loiseau; Sébastien Pomel
Journal:  Clin Transl Sci       Date:  2021-03-01       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.